MV100040: Tris-GalNAc-β-Ala-PEG4-DBCO label-new anticoagulant and growth-factor signaling research

anticoagulant and growth-factor signaling research

C12H19NNa2O14S / 479

Synthetic MUC-1 (di-STn) glycopeptide with C-terminal Cysteine

aa length 8) with Tn antigen (GalNAc) at Ser21

Fmoc-L-Asn(GlcNAc(Ac)3-β-D)-OH

MV100040: Tris-GalNAc-β-Ala-PEG4-DBCO label-new anticoagulant and growth-factor signaling researchC94H149N13O35 2021. 25 A triantennary N acetylgalactosamine (Tri GalNAc) ligand presenting three GalNAc residues on a tris based branched scaffold, extended through a alanine linker and a discrete tetraethylene glycol (PEG4) spacer to a terminal dibenzocyclooctyne (DBCO) handle. The DBCO group reacts with azide functionalized partners via copper free strain promoted azide alkyne cycloaddition (SPAAC), forming stable 1,2,3 triazole linkages without a